A new option for adults who have experienced stroke will now be available to further reduce future risk.
News|Articles|July 25, 2005
Here come new items for a pain-free summer
Yes, it's summer. The best time of the year. But it's also when consumers get aches, pains, cuts, scratches, and insect bites from participating in outdoor activities.
Advertisement
Yes, it's summer. The best time of the year. But it's also when consumers get aches, pains, cuts, scratches, and insect bites from participating in outdoor activities.
What new items will consumers have at their disposal this year?
Advertisement
Related to this article
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Asundexian, First FXIa Inhibitor for Stroke Prevention
2
The Outcome-Based Program That Could Reshape Pharmacists’ Roles
3
High Triglycerides Independently Linked with Severe COVID-19 Death
4
US Lost Over 3000 Pharmacies From 2022 to 2024, Mostly Chains
5